Literature DB >> 23664770

RETRACTED: Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes.

Christina Galloway1, Munmun Chattopadhyay2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Image duplication has been observed within Figure 1g-h. The corresponding author has been asked to provide an acceptable explanation for this duplication but has not been able to do so neither have the original source files been supplied. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664770     DOI: 10.1016/j.cyto.2013.04.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  15 in total

Review 1.  Inflammation: therapeutic targets for diabetic neuropathy.

Authors:  Jiyin Zhou; Shiwen Zhou
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

Review 2.  Diabetic neuropathic pain: Physiopathology and treatment.

Authors:  Anne K Schreiber; Carina Fm Nones; Renata C Reis; Juliana G Chichorro; Joice M Cunha
Journal:  World J Diabetes       Date:  2015-04-15

3.  Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

Authors:  Ryan B Griggs; Renee R Donahue; Braxton G Adkins; Katie L Anderson; Olivier Thibault; Bradley K Taylor
Journal:  J Pain       Date:  2015-12-12       Impact factor: 5.820

Review 4.  Treatment of painful diabetic neuropathy.

Authors:  Saad Javed; Ioannis N Petropoulos; Uazman Alam; Rayaz A Malik
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

5.  Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy.

Authors:  Md Habibur Rahman; Mithilesh Kumar Jha; Jong-Heon Kim; Youngpyo Nam; Maan Gee Lee; Younghoon Go; Robert A Harris; Dong Ho Park; Hyun Kook; In-Kyu Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2016-01-14       Impact factor: 5.157

6.  Sodium channel Nav1.7 expression is upregulated in the dorsal root ganglia in a rat model of paclitaxel-induced peripheral neuropathy.

Authors:  Zhongyuan Xia; Yun Xiao; Yang Wu; Bo Zhao
Journal:  Springerplus       Date:  2016-10-06

7.  Fractalkine signaling in regulation of insulin secretion.

Authors:  Brigid Gregg; Carey N Lumeng; Ernesto Bernal-Mizrachi
Journal:  Islets       Date:  2014       Impact factor: 2.694

8.  CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy.

Authors:  Daniela Maria Menichella; Belmadani Abdelhak; Dongjun Ren; Andrew Shum; Caroline Frietag; Richard J Miller
Journal:  Mol Pain       Date:  2014-06-25       Impact factor: 3.395

9.  Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice.

Authors:  Ken-Ichiro Tanaka; Shota Sekino; Megumi Ikegami; Hiroko Ikeda; Junzo Kamei
Journal:  J Exp Pharmacol       Date:  2015-06-24

10.  shRNA mediated knockdown of Nav1.7 in rat dorsal root ganglion attenuates pain following burn injury.

Authors:  Weihua Cai; Jing Cao; Xiuhua Ren; Liang Qiao; Xuemei Chen; Ming Li; Weidong Zang
Journal:  BMC Anesthesiol       Date:  2016-08-11       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.